Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Enanta Pharmaceuticals Inc. buy Rodman & Renshaw

Start price
€10.60
26.03.26 / 50%
Target price
€17.30
26.03.27
Performance (%)
0.94%
Price
?
08:10
Summary
This prediction is currently active. Since the start of the prediction for Enanta Pharmaceuticals Inc. the price has only changed by 0.94%. This prediction currently runs until 26.03.27. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this prediction
Performance without dividends (%)
Name 1w
Enanta Pharmaceuticals Inc. 0.94%
iShares Core DAX® -1,74 %
iShares Nasdaq 100 -2,58 %
iShares Nikkei 225® -1,16 %
iShares S&P 500 -1,42 %

Comments by Rodman___Renshaw for this prediction

In the thread Enanta Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 0.94%
Target price 17.302
Change
Ends at 26.03.27

Enanta Pharmaceuticals (ENTA) is now covered by Rodman & Renshaw. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat